← Leaderboards
Maria Grazia Ferrari
Advanced Bioscience Laboratories, Inc.
$734,396
Attributed
$734,396
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $703.2K · FY2020–21$1M$750K$500K$250K$0
'20
'21
Funding mix
By agency
NIH$734,396 · 1
By mechanism
N01$734,396 · 1
Top collaborators
No co-investigators on record.
Most similar at Advanced Bioscience Laboratories, Inc.
Same institution · by research overlap
- Timothy Fouts$52,990,932
- Peter Silvera$18,392,128
- Glenn Swartz$1,044,520
- Ranajit Pal$45,474,422
- Fred Mack$9,334,595
Others in their field
Other Emerging Leaders on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Valerie Koch · University Corporation For Atmospheric Res$245,119,768
- Leonard Freedman · Leidos Biomedical Research, Inc.$230,221,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$128,821,882
Research focus
ResourcesMicrobicidePre-ClinicalPreventionNational Institute Of Allergy And Infectious DiseaseSexual Hiv TransmissionAids PreventionPreventPre-Exposure ProphylaxisPrevention StrategyTechnologyResearch Clinical TestingClinical TrialsHiv InfectionsLicensureAcquired Immunodeficiency SyndromePlayPreventive VaccineAnti-Hiv MicrobicideUnited States National Institutes Of HealthProduct DevelopmentResearch StudyTarget PopulationsHiv Prevention Trial
Grant awards (5)
Development and Testing of Messaging to Drive Adoption and Use of HIV Prevention Products Among Young, Urban and Peri-Urban South African Women$31,175
N01 · FY2021 · AI · contact PI
STATISTICAL AND PHARMACOMETRIC MODELING SUPPORT FOR HIV NON-VACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT$261,386
N01 · FY2020 · AI · contact PI
Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques$158,927
N01 · FY2020 · AI · contact PI
Ethnographic Expertise for Enhancing Study Drug Adherence in HIV Prevention Trials$142,410
N01 · FY2020 · AI · contact PI
Support for Enhancing Study Drug Adherence in HIV Prevention Trials$140,498
N01 · FY2020 · AI · contact PI